BiotechTube
Home/Bullseye Biosciences/Andy Gooden, MSEE
AG

Andy Gooden, MSEE

Co-Founder

Bullseye Biosciences

Therapeutic Areas

Oncology

Bullseye Biosciences Pipeline

DrugIndicationPhase
Vascularized Heart Organoid PlatformDrug discovery/toxicity screening, Disease modelingPre-clinical
Vascularized Liver Organoid PlatformDrug discovery/toxicity screening, Disease modelingPre-clinical

Leadership Team at Bullseye Biosciences

OA
Oscar Abilez, MD, PhD
Co-Founder
FM
Frankie Myers, PhD
Co-Founder
View full Bullseye Biosciences profile